Australia

GLOBAL HEALTH LIMITED (GLH)

Track

No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Mathew Cherian Director
Transaction date
Sale
Price
145.76
Quantity 88,996
Value A$408,824
Grant Smith Director
Transaction date
Purchase
Price
485.73
Quantity 77,081
Value A$3,519,662
Steven Pynt Director
Transaction date
Purchase
Price
329.70
Quantity 60,300
Value A$1,271,579
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2022-11-14 2022-11-11 S Sale Mathew Cherian Director
88,996
145.76
A$408,824 		88,996 145.76 A$408,824
2022-11-14 2022-11-07 B Purchase Grant Smith Director
77,081
485.73
A$3,519,662 		77,081 485.73 A$3,519,662
2022-10-28 2022-10-26 B Purchase Steven Pynt Director
60,300
329.70
A$1,271,579 		60,300 329.70 A$1,271,579
Explore more

More insider trading research around GLOBAL HEALTH LIMITED

More insider trades in Australia
Insider trading in Asia-Pacific